Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk.

Int J Chron Obstruct Pulmon Dis · 2016 · PMC4694692 · PMID 26730183

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Because the primary endpoint difference did not reach statistical significance, all differences reported for the secondary efficacy endpoints are presented descriptively only as statistical inference cannot be made.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.